Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex biologics. Enhancing these processes involves fine-tuning various parameters, including cell line development, media composition, and bioreactor conditions. A key goal is to maximize antibody production while lowering productio